Chun et al., Weight loss and body composition after compounded semaglutide treatment in a real world setting, Diabetes Obesity and Metabolism , Jan
For more information on Numerators GLP-1 insights and offerings, head over to our GLP-1 Research Hub or get in touch with our team.
GLP-1 receptor agonists approved for use in the UK include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)
Thirty-two male mice were started on a 60% high-fat diet of 5.24 kcal/g at three weeks of age for 19 weeks, followed by a 45% HFD of 4.73 kcal/g for six additional weeks
Structural Information Classification: Dual-peptide stack Form: Lyophilized vial presentation Catalog Strengths: 10mg/10mg Research Applications Used in controlled laboratory settings for receptor-signaling models, comparative pathway analysis, presentation or stability work where applicable, and other non-clinical analytical workflows consistent with authorized research use